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Abstract
Recent scientific evidence has indicated that the elderly have increased risk of COVID-19 infections, with over 70s and 80s being hardest
hit – especially residents of care homes and in clinical settings, ethnic minorities, people who work indoors and those who are overweight
and obese. Other potential risk factors include lack of exposure to sunlight, darker skin pigmentation, co-morbidities, poor diet, certain med-
ications, disadvantaged social and economic status, and lifestyle factors such as smoking and excessive consumption of alcohol. A key question
is to understand how and why certain groups of people are more susceptible to COVID-19, whether they have weakened immune systems and
what the roles of good nutrition and specific micronutrients are in supporting immune functions. A varied and balanced diet with an abundance
of fruits and vegetables and the essential nutrients like vitamin D, vitamin A, B vitamins (folate, vitamin B6 and vitamin B12), vitamin C and the
minerals, Fe, Cu, Se and Zn are all known to contribute to the normal functions of the immune system. Avoidance of deficiencies and
identification of suboptimal intakes of these micronutrients in targeted groups of patients and in distinct and highly sensitive populations could
help to strengthen the resilience of people to the COVID-19 pandemic. It is important to highlight evidence-based public health messages, to
prevent false and misleading claims about the benefits of foods and food supplements and to communicate clearly that the extent of knowledge
between micronutrients and COVID-19 infection is still being explored and that no diet will prevent or cure COVID-19 infection. Frequent
handwashing and social distancing will be critical to reduce transmission.
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The risk of COVID-19 infection and death increases significantly
among older people(1), especially those over 70 and 80 years,
and those with co-morbidities such as obesity, CVD, hyperten-
sion and diabetes(2). Of particular interest is the disproportionate
number of deaths in black, Asian and ethnic minorities(3). In the
UK, two-thirds of healthcare workers who have died from
COVID-19 were from ethnic minorities, including doctors, den-
tists, nurses, midwives and healthcare support workers(3).
Many of the risk factors identified so far that are related to viral
infections and deaths from COVID-19 have underlying associa-
tions with nutritional status and specific essential nutrients that
are known to contribute to the normal functions of the immune
system. Important nutrients that support the immune function
include vitamins A and D, the B vitamins (folate, vitamins B6
and B12) and vitamin C, and the minerals and trace elements
Zn, Fe, Se and Cu(2,4–6).
Deficiencies and suboptimal nutritional status of these
micronutrients can potentially decrease resistance to infections
and reinfections. Deficiencies of nutrients develop progres-
sively over time, and several subclinical stages occur long
before clinical symptoms of deficiency appear, including
depletion of nutrient stores, biochemical adaptations and
impairments of metabolic pathways and functions(7).
Validated biomarkers for the micronutrients supporting the
immune responses are available and can provide evidence
about baseline nutritional status, dietary exposure, impact of
nutritional interventions and genetic factors influencing micro-
nutrient metabolism(8–11). Gradually, the different lines of evi-
dence from clinical, nutritional, epidemiological and
mechanistic studies are helping to elucidate plausible and bio-
logically relevant relationships between nutritional status and
risk of COVID-19.
This evidence can help develop advice for governments and
health professionals concerning how best to target vulnerable
groups of the population and to identify nutritional policy
solutions.
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; ARTI, acute respiratory tract infection.
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Vulnerability of people who are deprived of sunlight
and are obese
Vitamin D directly affects immune responses, and there are
many potential mechanisms by which it may reduce the risks
of viral and bacterial infections(12–15). The major source of
vitamin D in humans can be via the action of UVB radiation in
sunshine on skin, with estimates of cutaneous synthesis provid-
ing 80–100 % of the vitamin D requirement of the body with
adequate sun exposure(14). Factors that prevent or impede
year-round dermal synthesis include season, latitude and pre-
vailing weather conditions, as well as skin pigmentation, age,
sunscreen usage, working environment, outdoor activity and
sun exposure behaviour. Melanin in skin reduces penetration
of UVB and thus contributes to lower vitamin D status in dark-
skinned individuals(14). In the absence of sufficient exposure
to sunlight, dietary sources of vitamin D, including conventional
foods high in vitamin D, fortified foods and food supplements,
are necessary to meet nutritional requirements and to avoid
vitamin D deficiency. To ensure optimal vitamin D status, use
of vitamin D supplements is often required, as sunlight exposure
and dietary intake are usually insufficient in many individuals(15).
Dermal synthesis of vitamin D may also be less efficient in older
people than in younger adults(13,14,16).
People who wear clothes that cover most of their body or
who are confined indoors, especially for extended periods of
time, and residents in care and nursing homes are very likely
to have low exposure to sunlight. In a systematic review of
the scientific literature researchers discovered that a high
percentage of indoor workers (91 %) had suboptimal vitamin D
status, which was highest among shift workers (80 % of individ-
uals) and healthcare students (72 %)(17). Sunlight deprivation
accounted for a higher risk of both vitamin D insufficiency
and deficiency, with healthcare workers among the most
vulnerable groups. The authors concluded that job type may
be a major factor in vitamin D deficiency and that guidelines
on screening for vitamin D nutritional status and mitigation
strategies, such as supplementation, should take into account
different jobs and shift patterns. These people, together with
those with low intakes of vitamin D in the diet, and those
who are socially or economically disadvantaged, are particularly
vulnerable to deficiencies and suboptimal nutritional status.
Furthermore, naturally rich sources of vitamin D in the diet
are few and infrequently consumed. Dietary supply of vitamin D
is typically unable to offset the widespread deficiency of
UVB-induced synthesis in the skin unless supplemental
vitamin D is used(13,18).
There is an association between obesity and low vitamin D
status, and obesity and inflammatory conditions increase the risk
of vitaminD deficiency(18). In a very recent study, the high preva-
lence of vitamin D deficiency in people in countries in the
Northern Hemisphere exposed to insufficient sunlight has been
hypothesised to be linked to a possible role of vitamin D in sup-
pressing the severe inflammatory responses seen in very ill
COVID-19 patients and in COVID-19 deaths(19). Obesity is also
associated with chronic inflammation in metabolic tissues, and
vitamin D is a potent immunomodulator and anti-inflammatory
agent. The constant state of low-grade inflammation,
characteristic of obesity, may therefore increase requirements
for vitamin D(20). The fact that obesity is associated with lower
blood 25-hydroxyvitamin D (25(OH)D) concentrations, a recog-
nised biomarker used to assess the risk of vitamin D deficiency
and suboptimal intakes(12–15), may be because the lipophilic pool
that forms the reservoir of vitamin D in the body is much greater
in obese subjects. Such individuals typically need longer expo-
sure to UVB radiation or higher amounts of vitamin D supple-
mentation than those of ideal BMI(21).
Undernutrition and malnutrition in the community
and residents of care and nursing homes
Across the UK, thousands of care homes are experiencing
COVID-19 infections and deaths among their residents, many
of whom are suffering from dementia. These elderly residents
of care homes are acutely vulnerable to COVID-19(4).
Undernutrition and malnutrition have been reported over many
decades among people in care and nursing homes and in hos-
pital patients(22–25). A significant proportion of hospitalised
patients show evidence of impaired nutritional status on admis-
sion to hospital including low blood 25(OH)D concentrations
and low levels of vitamins B1, B2, B6, folate and vitamin C(24).
Patient outcomes are quite likely to be affected by increased
medical complications impacting on length of stay and
convalescence, severity of the disease, decreased survival rates
and ability to live at home(24).
Common nutritional problems in the community and in care
homes are low energy intakes, weight loss and vitamin and
mineral deficiencies(26,27) due to loss of appetite and age-related
loss of senses of taste and smell for reasons including illness,
infections and some medications(28). Sarcopenia, depression,
co-morbidities such as obesity, changing body composition with
increased adiposity and loss of lean body mass, hypertension,
diseases of the intestinal tract (resulting in impaired absorption
of nutrients), lack of intrinsic factor for absorption of vitamin B12,
respiratory diseases and cognitive impairments are also
common(24,25). Vitamin D deficiency-related co-morbidities
also include liver and kidney diseases, and organ transplant
recipients are particularly vulnerable(29,30). Psychological and
emotional stress such as loneliness, loss of loved ones, anxiety
and depression can all have negative effects on physical and
mental health and well-being. Medications such as antibiotics,
anti-hypertensive, anti-inflammatory, anti-seizure and endocrine
drugs are contraindicated for vitamin D and can lead to lower
blood 25(OH)D concentrations and interfere with vitamin D
functions in the body(31).
Vitamin D, respiratory and cardiovascular health
and optimal nutritional status
The metabolism and actions of vitamin D are well known in
relation to bone health, but increasing evidence is emerging
about its role in respiratory health, including potential impact
on inhibiting pulmonary inflammatory responses and enhancing
innate defence mechanisms against respiratory pathogens(2,5).
Circulating blood 25(OH)D concentrations have been associated
2 D. P. Richardson and J. A. Lovegrove
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with normal lung function, and there is an increasing evidence-
based scientific rationale for the immunomodulant, anti-
inflammatory and anti-infective actions of vitamin D(15). For
example, in a systematic review and meta-analysis, vitamin D
was shown to protect against acute respiratory tract infections
(ARTI), and patients who were severely vitamin D deficient
experienced the most benefit(32). It has also been shown that
there is a linear association between vitamin D status and respi-
ratory infections and lung function(33). The UK Scientific
Advisory Committee on Nutrition has recently undertaken a
rapid review of vitamin D and ARTI(34). This review noted that
currently, the interpretation of the evidence on vitamin D and
ARTI was complicated because of differences in vitamin D thera-
peutic doses and regimens, study settings, participants, study
duration, definitions and verification of outcomes (including
type of respiratory infection). Since 2017, evidence has
suggested that, overall, there is no effect of vitamin D supple-
mentation on reducing ARTI risk, and Scientific Advisory
Committee on Nutrition concluded that the evidence at this time
does not support recommending vitamin D supplementation to
prevent ARTI in the general population. Nevertheless, Scientific
Advisory Committee on Nutrition will keep this topic under
urgent review if emerging evidence on vitamin D and ARTI risk
suggests a change to existing conclusions is warranted(34).
In a review of epidemiological evidence, cardiovascular
risks and events have been associated with low vitamin D
concentrations(35). Vitamin D is associated with cardiovascular
benefits and the regulation of blood pressure with some
evidence of its effect on reducing vascular stiffness and vascular
dysfunction, although the data are inconsistent(18). Higher
vitamin D status has also been associated with a lower risk
of type 1 and type 2 diabetes(18). The risk of heart failure has
also been reported to be 12-fold higher in elderly people
who are vitamin D deficient. This association shows a higher
risk than obesity or heart arrythmia(36). Lifestyle factors, such
as regular smoking, people living in population-dense urban
areas or overcrowded living conditions and in regions
impacted by air pollution, people unable to go outside into
the sunshine, people who are malnourished, overweight or
obese(37) or who drink excessive amounts of alcohol and those
with low baseline blood 25(OH)D concentrations, or combina-
tions of all these potentially confounding factors, are likely to
have weakened immune systems and functions and be at
increased risk of viral infections(2,4,5,38). The benefits of an
active outdoor lifestyle and a varied and healthy balanced diet
cannot be overemphasised.
Diet and nutrition surveys and nutritional status of the
UK population
The UK National Diet and Nutrition Surveys of nutrient intake
and nutritional status published in 2019(39) have shown a sus-
tained worsening of the dietary intakes and chronic shortages
of several of the nutrients involved in supporting the normal
immune functions, including vitamin D, vitamin B12, Zn, Se,
Cu and vitamins A and C. Low intakes of these essential nutrients
over a 9-year period are evident in the general population of all
age/sex groups. For example, an analysis of UK Biobank data(40)
found that vitamin D intakes from the diet of Bangladeshi, Indian
and Pakistani individuals ranged from 1·0 to 3·0 μg/d – well
below the Public Health England and Scientific Advisory
Committee on Nutrition recommendations for 10 μg/d(16)
and the European Food Safety Authority adequate intake of
15 μg/d(41). Vitamin D supplementation was low amongst UK
South Asians, with only 22 % of Bangladeshis, 32 % of Indians
and 25 % of Pakistanis taking a vitamin D supplement. Within
this group of South Asians, women (39 %) were more likely to
take a supplement than men (23 %)(40). Interestingly, an analysis
of the UK Biobank cohort showed a very high prevalence of low
levels of blood 25(OH)D and vitamin D deficiency in UK/South
Asian adults(37). However, in a recent study, the UK Biobank
Data provided no evidence that plasma 25(OH)D concentrations
explained susceptibility to COVID-19 infection, either overall or
observed differences between ethnic groups(42). This conclusion
has been subsequently challenged(43), and further clinical
and epidemiological studies are required to unravel the conflict-
ing results.
The National Diet and Nutrition Surveys findings in 2018 of
the micronutrient intakes for adults aged 65–70 years and
75 years and over showed that for vitamin D, mean intakes were
35 %of the Reference Nutrient Intake for adults aged 65–74 years
and 28 % Reference Nutrient Intake for those over 75 years.
Inclusion of intakes from vitamin D food supplements brought
the mean intakes up to 60 and 53 % for those age groups,
respectively(44).
Vegetarian and vegan diets(45) can also generally be low in
nutrients such as vitamin B12, Zn, Cu, Fe and Se aswell as vitamin
D and the n-3 long-chain fatty acids DHA and EPA found mainly
in oily fish and cod liver oil. In fact, the high prevalence of
vegetarianism and the avoidance of all foods of animal origin
in Indian and ethnic minorities could exacerbate deficiencies
and suboptimal intakes of all these essential nutrients. For
example, Zn bioavailability is influenced by high-fibre diets
and their phytate content because of the binding of Zn by these
components in plant-based foods, particularly grains and
legumes. Dietary phytate is known to be a contributory factor
for Zn deficiency(46,47).
In a study of sevenWestern countries of intakes and deficien-
cies of eight trace elements in older adults (≥60 years)(27),
Se deficiency was observed in 49 % of women and 37 % of
men living in the community and 44 % of women and 27 % of
men in care homes, nursing homes and retirement homes. Zn
deficiency was also observed in 31 % of community-based
women and 49 % of men. Significant proportions of both older
populations showed insufficiencies not only of Zn and Se but
also for Fe, iodine and Cu(27).
For Se, the 2018 National Diet and Nutrition survey(44)
showed that a substantial proportion of older adults in all
age/sex groups had intakes below the lower nutrient reference
intake, that is high risk of deficiency. Of those aged 75 years or
older, 34 % of men and 57 % of women had intakes below the
lower nutrient reference intake. Of women aged 75 years and
over, 12 % had intakes below the lower nutrient reference intake
for Fe and Zn compared with 8 and 3 %, respectively, in women
aged 65–74 years.
Nutritional status of micronutrients 3
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Nutrients contributing to the normal functions of the
immune system
Several essential nutrients contribute to the normal functions of
the immune system. Zn has a role in antiviral immunity(48), and
deficiency of dietary Zn has been reported to increase suscep-
tibility to infectious diseases. Zn has also been given as an effec-
tive adjunct treatment in reducing mortality from severe
pneumonia(49).
The risk of viral infections and several chronic diseases is
modified by low Se intakes and nutritional status(50,51).
Selenoproteins such as glutathione peroxidase play a crucial role
in the body’s response to oxidative stress(50,51). During
viral infection, the pathogens induce oxidative stress by
generating reactive oxygen species in host cells, which, if not
counterbalanced by antioxidant defence mechanisms, leads to
oxidative stress and the emergence of more virulent strains(48,52).
The Se content of plant and animal products can vary 10-fold
according to soil and geographic origin, and the lowest Se status
is found in populations that eat vegetarian diets including plants
grown in low-Se areas of the world(53). Potentially relevant to the
recent appearance of COVID-19 in China is the association
between lower regional Se nutritional status and more severe
reported outcomes of COVID-19 cases in different regions of
China(53), although that does not prove cause and effect.
Multiple cellular and viral mechanisms involving Se and seleno-
proteins could influence viral pathogenicity, severity and dura-
tion of respiratory symptoms, recovery and death rates from
COVID-19(52).
Cu-related enzyme cytochrome c oxidase is needed for
energy production of immune cells and another cupro-enzyme,
superoxide dismutase, plays a role in the protection of immune
cells against reactive oxygen species. Moderate or even
marginal Cu deficiency affects some activities of T lymphocytes
and phagocytic cells adversely(54,55). Although evidence
for impaired function of the immune system resultant from
Fe deficiency in humans is scarce, changes have been
demonstrated in in vitro tests and animal models. These
mechanistic observations resulted in European Food Safety
Authority concluding that a cause and effect association has
been established between dietary status of Fe and a normal
immune function(56).
In addition to the functions of vitamin D, vitamin A has crucial
immunomodulatory roles, and vitamin Ametabolites exert direct
effects on immune functions(47,57). Vitamin A deficiency is asso-
ciated with impaired intestinal immune responses and increased
risk of infectious morbidity and mortality in relation to gastroin-
testinal and respiratory infections. Preformed vitamin A (retinol)
is only found in animal-derived foods. Carotenoid precursors of
vitamin A, such as β-carotene, are abundant in green leafy veg-
etables and certain fruits, but intakes of fruits and vegetables in
the UK are still well below the recommended number of five-a-
day servings. TheNational Diet andNutrition Surveys 2019 states
that the proportion of people meeting the five-a-day target
remains low, at about 30 % for adults and about 10 % for 11-
to 18-year-olds(39).
There is no evidence of direct immune impairments in vita-
min E-deficient individuals and a restoration of a depressed
immune system by the vitamin(58), although vitamin E has impor-
tant immunomodulatory effects and may confer protection
against infectious diseases(59). For example, clinical outcomes
demonstrate a role for vitamin E in reducing the risk of respira-
tory tract infections by improving immune response in elderly
nursing home residents(60,61).
Vitamin C contributes to normal immune functions and the
inhibition of inflammatory processes(62). Vitamin C deficiency
results in impaired immunity and higher susceptibility to
infections. In turn, infections significantly impact on vitamin C
levels due to enhanced inflammation and increased metabolic
requirements(62). Vitamin C appears to exert a number of
beneficial effects on cellular functions of both the innate and
adaptive immune systems(62). In addition, it has a very effective
antioxidant role per se, but it is also needed for the regeneration
of vitamin E(62). There are numerous factors that can affect
vitamin C status, including dietary intake, obesity, severe infec-
tions, institutionalisation and smoking(63). Smokers with low
intakes of vitamin C show increased oxidative stress, and
plasma vitamin C is decreased by about 40 % in male smok-
ers(62). Vitamin C status, as measured by plasma and leucocyte
concentrations, is lower in elderly people with chronic
illnesses, especially in care and medical settings, compared
with young adults(62).
Other important water-soluble vitamins that contribute to the
normal immune functions are the B vitamins folate, B6 and
B12(64–66). Vitamin B6 is required as a coenzyme in the metabo-
lism of antibodies and cytokines. Lymphocytes isolated from
vitamin B6-deficient people display reduced proliferation,
reduced IL-2 production in response to mitogens and reduced
antibody production in response to immunisation(65,67).
Folate plays a crucial role in nucleotide synthesis and thus
may affect immune cell proliferation and responsiveness.
Folate deficiency has been shown to reduce proliferation of
various cell types and to reduce the proportion of circulating
T lymphocytes and their proliferation in response to mitogen
activation. In vitro studies demonstrated that all the effects on
the immune system were reversible either by folate addition
or nucleotide repletion(64,68).
Vitamin B12, along with vitamin B6 and folate, is involved in
the immune functions through their involvement in nucleic acid
and protein biosynthesis. Decreased availability of vitamin B12
for rapidly proliferating B lymphocytes is believed to result in
an impaired antibody response to pneumococcal polysaccha-
ride vaccine and synthesis of specific Ig(66,67).
Based on scientific assessments carried out by European
Food Safety Authority, the European Register of authorised
nutrient function health claims1(69) include the specific nutrients
vitamin A (including β-carotene), vitamin D, the B vitamins
(folate, vitamins B6, B12), vitamin C and the essential minerals
and trace elements Fe, Cu, Zn and Se for their contributions to
the normal functioning of the immune system(69). However, to
date, there have been no direct associations between status of
these micronutrients and COVID-19 infection.
1A form of claim that refers to the physiological role of the nutrient in growth,
development and normal functions of the body (Regulation EC 1924/2006).
4 D. P. Richardson and J. A. Lovegrove
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Strategies to avoid nutritional deficiencies and ensure
adequacy of micronutrient status in different populations
The primary public health and nutrition strategy is to provide
advice on the importance of a varied and balanced diet and a
healthy lifestyle. However, when there is evidence of non-
compliance with this advice, and where diet and nutrition
surveys demonstrate inadequate micronutrient intakes and
prevalence of low nutritional status, national nutrition strategies
also include the addition of micronutrients to commonly eaten
foods such as vitamin D added to margarines and fat spreads
(food fortification) and the use of food supplements(13,70).
Overall, micronutrient status, particularly vitamin D status,
may be exacerbated during this COVID-19 pandemic as a result
of the restrictions on movements, which may impair normal
immune functions(2,4–6,71). Very recently, studies have shown
that vitamin D plays a role in regulating and suppressing the
cytokine inflammatory response that causes the acute respira-
tory distress syndrome observed in severe and often lethal forms
of COVID-19(71). In addition, a significant correlation has been
shown between low serum vitamin D levels and mortality from
COVID-19(72,73).
As this review illustrates, vitamin D is not the only essential
nutrient known to contribute to normal functioning of the
immune system(2,5,74). It has been suggested by some researchers
that, in addition to the consumption of a well-balanced diet,
other nutrients such as vitamin C, Zn and the n-3 fatty acids
EPAþDHA at levels above the daily reference values, may help
reduce nutritional gaps, support optimal immune functions and
possibly reduce risk and consequences of infection(2,5). Dietary
approaches to achieve a healthy gut microbiota may also benefit
the immune system(71).
In recent reviews of the therapeutic uses of vitamin D to pre-
vent or treat ARTI, and data from human intervention trials on
COVID-19 patients, using pharmacological doses, there was
no evidence of any specific therapeutic effect. However, both
reports(34,75) advised that all people should continue to follow
the UK Government advice on daily vitamin D supplementation
of 10 μg/d to maintain bone and muscle health during the
COVID-19 pandemic, since people may not be getting enough
from sunlight exposure or diet. In a further rapid review, the
Royal Society(76) agreed that there is no direct causal link yet
between vitamin D deficiency and increased susceptibility to
COVID-19. However, this report pointed out that the UK has
one of the highest levels of vitamin D deficiency in Europe
and that it would be prudent for the Government to provide a
stronger public health message about avoiding vitamin D defi-
ciency. Despite social media attention and claims for high-dose
therapeutic benefits of some nutrients, it is key to prevent false or
misleading claims2(5,6) that diet or individual micronutrients can
either ‘boost’ the immune system or ‘prevent’ or ‘cure’ COVID-19
infection. Indeed, medicinal claims for prevention, cure and alle-
viation of a disease for foods and food supplements are illegal in
the UK and the European Union as a whole(77). Furthermore,
consumption of excessive quantities of some micronutrients
can have adverse metabolic and health effects, and total intakes
of each nutrient from all food and food supplement sourcesmust
take into account the tolerable upper safe level set by expert sci-
entific committees such as European Food Safety Authority(78),
the Food and Nutrition Board/Institute of Medicine in the
USA(31,47,79) and the UK Expert Vitamin and Mineral Group(80).
In conclusion, avoidance of nutrient deficiencies, identifica-
tion of target groups at high risk of suboptimal nutritional status
and the use of practical, safe and effective nutrition policy
solutions may help strengthen the resilience of people to the
COVID-19 pandemic. Further research and the greater
understanding of potential nutritional risk factors could help
explain why certain groups of people are more susceptible to
COVID-19. The evolving information will contribute to the
evidence base for dietary counselling on healthy weight and
the role of the essential micronutrients in supporting immune
functions, as well as for the development of clinical guidelines
and effective public health strategies on nutrition and health.
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